In previous studies, another CD44 binding peptide, A6, was found to enhance cell adhesion to HA and induce FAK and MEK phosphorylation in a CD44 dependent manner in breast and ovarian cancer cells [56]. Here, MAP2K7 is linked to ovarian cancer.